Lamanna Details Evolution of CLL Treatment Following
Resistanceonclive.com/view/lamanna-de...
November 8, 2023
onclive.com/view/data-conti...
Data Continue to Refine Frontline BTK Inhibitor Selection in CLL ( Furman)
Second Generation BTK Inhibitors Improve Survival in R/R CLL Setting (Weirda)